• Users Online: 943
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2021| January-June  | Volume 7 | Issue 1  
    Online since June 25, 2021

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEW ARTICLES
Crisaborole for the treatment of atopic dermatitis in Indian patients: An evidence-based consensus statement
Kiran Godse, Abhiesh De, Nidhi Sharma, Murlidhar Rajagopalan, Bela Shah, Mukesh Girdhar, Vijay Zawar, Kupra Shankar, Gauri Godse, Anant Patil
January-June 2021, 7(1):7-11
DOI:10.4103/ijdd.ijdd_35_20  
  3,319 118 -
Food and drug interactions in dermatology: Maximizing drug safety and efficacy through intelligent dispensing
Anwita Sinha, Shekhar Neema
January-June 2021, 7(1):1-6
DOI:10.4103/ijdd.ijdd_24_20  
  2,046 107 -
Ligelizumab: A promising option on the horizon for the management of chronic spontaneous urticaria
Kiran Godse, Anant D Patil, Gauri Godse
January-June 2021, 7(1):12-14
DOI:10.4103/ijdd.ijdd_33_20  
  1,644 67 -
ORIGINAL ARTICLES
Oral itraconazole and topical eberconazole therapy in the treatment of tinea cruris and corporis
Dattatray G Saple, Sushrut Save, Swagata Arvind Tambe
January-June 2021, 7(1):15-19
DOI:10.4103/ijdd.ijdd_44_19  
  1,461 97 -
Topical 0.1% adapalene gel versus 0.1% adapalene and 2.5% benzoyl peroxide combination gel in the treatment of mild-to-moderate acne vulgaris: An open-label randomized controlled pilot study
Madai Puthiyaveedu Amrutha, Joy Bifi, Thyvalappil Anoop, Sreenivasan Ajayakumar, K Radhakrishnan, Sridharan Rajiv
January-June 2021, 7(1):20-23
DOI:10.4103/ijdd.ijdd_29_20  
  1,337 73 -
LETTERS TO EDITOR
Imatinib mesylate-induced palmoplantar keratoderma
Niharika Jha, Bimal Kanish, Anuradha Bhatia
January-June 2021, 7(1):49-50
DOI:10.4103/ijdd.ijdd_17_20  
  1,332 44 -
CASE REPORTS
Dual drug reactions induced by a single drug: A rare phenomenon
Angoori Gnaneshwar Rao, Vangali Srikanth Reddy, Kousar Fathima, M Tejal, Divya Muppirala, Preethi Sunki, CH Sruthi, Jayshree Jhawar, Vidyadharani Myneni
January-June 2021, 7(1):29-31
DOI:10.4103/ijdd.ijdd_17_19  
  1,050 48 -
Generalized bullous fixed drug eruption due to fluconazole: A report of two cases
Anuva Bansal, Vineet Relhan, Bijaylaxmi Sahoo
January-June 2021, 7(1):32-35
DOI:10.4103/ijdd.ijdd_32_20  
  949 58 -
Lichenoid drug eruption due to isoniazid presenting as generalized exfoliative dermatitis in an immunocompromised patient
Preema Sinha, Siddharth Bhatt, Prateek Kinra, Subramaniyan Radhakrishnan, Shivali Awasthi
January-June 2021, 7(1):36-39
DOI:10.4103/ijdd.ijdd_22_20  
  914 40 -
BRIEF REPORT
A multicentric, prospective and retrospective analysis of Stevens–Johnson syndrome, toxic epidermal necrolysis and Stevens–Johnson syndrome/toxic epidermal necrolysis overlap: An Indian perspective
Ramesh Marne Bhat, Jyothi Jayaraman, Navyashree Suresha, Sukumar Dandekeri, Myfanwy Joanne D'souza
January-June 2021, 7(1):24-28
DOI:10.4103/ijdd.ijdd_63_19  
  903 46 -
LETTERS TO EDITOR
Bosentan: A newer option to treat digital ulcers in patients of systemic sclerosis
Shreeparna Deb, Pankaj Kumar Tiwary, Anupama Singh
January-June 2021, 7(1):44-45
DOI:10.4103/ijdd.ijdd_27_20  
  906 38 -
CASE REPORTS
Lichen planus pemphigoides versus bullous pemphigoid: A diagnostic dilemma of cutaneous adverse event in a case of nonsmall cell lung cancer treated with durvalumab
Ketki Shekhar Bhoite, Sunanda Arun Mahajan, Shefali A Saini
January-June 2021, 7(1):40-43
DOI:10.4103/ijdd.ijdd_11_20  
  858 32 -
LETTERS TO EDITOR
Imatinib mesylate-induced psoriasiform drug reaction: A case of dose-dependent cutaneous toxicity
Aditya Holani, Swapna Khatu, Rajvardhan Bagane, Aishwarya Bedi
January-June 2021, 7(1):46-48
DOI:10.4103/ijdd.ijdd_25_20  
  732 40 -